Feb 6 (Reuters) - AbbVie Inc (NYSE:ABBV) ABBV.N :
* ABBVIE RECEIVES A POSITIVE RECOMMENDATION FROM THE CADTH CANADIAN DRUG EXPERT COMMITTEE FOR MAVIRET - AN ORAL THERAPY FOR THE TREATMENT OF PATIENTS WITH HEPATITIS C
Feb 6 (Reuters) - AbbVie Inc (NYSE:ABBV) ABBV.N :
* ABBVIE RECEIVES A POSITIVE RECOMMENDATION FROM THE CADTH CANADIAN DRUG EXPERT COMMITTEE FOR MAVIRET - AN ORAL THERAPY FOR THE TREATMENT OF PATIENTS WITH HEPATITIS C